Eleanor N. Fish
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Eleanor N. Fish has a total of 245 co-authors. Here are the top co-authors by number of shared publications:
- Leonidas C. Platanias
Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL 60611, USA
41 shared publications - Diana Saleiro
Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois
33 shared publications - Elspeth M. Beauchamp
Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois
33 shared publications - Mariafausta Fischietti
Northwestern University 1 Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois
33 shared publications - Alain Mina
Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, USA
17 shared publications - Atul Jain
Northwestern University 4 Department of Chemistry Evanston, Illinois
17 shared publications
Latest Publications
- Open Access
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 4 from Development of a SIN1 Targeting Inhibitor as a Novel Therapeutic Approach for the Treatment of Malignancies
Metascape analysis of SIN1 IP proteomics
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 4 from Development of a SIN1 Targeting Inhibitor as a Novel Therapeutic Approach for the Treatment of Malignancies
Metascape analysis of SIN1 IP proteomics
- Open Access
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 8 from Development of a SIN1 Targeting Inhibitor as a Novel Therapeutic Approach for the Treatment of Malignancies
Quantification of Western blots from Figure 1F-G
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 8 from Development of a SIN1 Targeting Inhibitor as a Novel Therapeutic Approach for the Treatment of Malignancies
Quantification of Western blots from Figure 1F-G
- Open Access
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 10 from Development of a SIN1 Targeting Inhibitor as a Novel Therapeutic Approach for the Treatment of Malignancies
Docked pose of hit compound NUCC-175662 bound to SIN1
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 10 from Development of a SIN1 Targeting Inhibitor as a Novel Therapeutic Approach for the Treatment of Malignancies
Docked pose of hit compound NUCC-175662 bound to SIN1
- Open Access
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 11 from Development of a SIN1 Targeting Inhibitor as a Novel Therapeutic Approach for the Treatment of Malignancies
NUCC-201760 inhibits other small RAS GTPase family members in addition to RAS
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 11 from Development of a SIN1 Targeting Inhibitor as a Novel Therapeutic Approach for the Treatment of Malignancies
NUCC-201760 inhibits other small RAS GTPase family members in addition to RAS
- Open Access
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 5 from Development of a SIN1 Targeting Inhibitor as a Novel Therapeutic Approach for the Treatment of Malignancies
Metascape analysis of SIN1 IP proteomics
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 5 from Development of a SIN1 Targeting Inhibitor as a Novel Therapeutic Approach for the Treatment of Malignancies
Metascape analysis of SIN1 IP proteomics
- Open Access
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from Development of a SIN1 Targeting Inhibitor as a Novel Therapeutic Approach for the Treatment of Malignancies
Supplementary Materials and Methods: Key Resource Table
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from Development of a SIN1 Targeting Inhibitor as a Novel Therapeutic Approach for the Treatment of Malignancies
Supplementary Materials and Methods: Key Resource Table